Related Experiment Videos
Control of the G1/S transition
1Department of Molecular Biology, Scripps Research Institute, La Jolla, California 92037, USA.
Cancer Surveys
|January 1, 1997
Summary
Cell cycle progression relies on regulating cyclin dependent kinase (CDK) activity, particularly at the G1/S phase transition. Key substrates like the retinoblastoma protein (RB) are crucial, and their dysregulation contributes to cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The G1/S phase transition is a critical checkpoint in the mammalian cell cycle.
- Regulation of this transition is primarily mediated by cyclin dependent kinases (CDKs).
Purpose of the Study:
- To review the current understanding of G1/S phase transition control.
- To highlight the role of CDKs and their substrates in cell cycle regulation and malignancy.
Main Methods:
- Literature review of cell cycle regulation mechanisms.
- Analysis of CDK complexes and their substrates.
- Discussion of signaling pathways influencing CDK activity.
Main Results:
- G1/S specific CDK activity involves complexes of D-type cyclins with CDK4/CDK6 and Cyclin E/A with CDK2.
- Cellular signals modulate CDK activity via cyclin levels, inhibitors, and phosphorylation.
- The retinoblastoma protein (RB) is a key CDK substrate, neutralizing its inhibitory role in G1 to S phase progression.
Conclusions:
- Dysregulation of cell cycle regulators, including CDKs, inhibitors, and substrates, is implicated in human cancers.
- Understanding CDK regulation is vital for cancer research and therapeutic development.